Alleviating Effect of Lafutidine on Toxicity of S-1: Adjuvant Chemotherapy with S-1 after curative treatment in patients with squamous cell carcinoma of the head and neck
Not Applicable
- Conditions
- Head and Neck squamous cell carcinoma
- Registration Number
- JPRN-UMIN000021137
- Lead Sponsor
- Tokyo medical university
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
1) Patient with active double cancer (synchronous double cancer and metachronous double cancer) 2) Patient with administration contraindication of S-1 and Lafutidine
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Completion rate of S-1 treatment according to planned
- Secondary Outcome Measures
Name Time Method 1) safety 2) Medication compliance